Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results

Peer Review reports

Original Submission
26 Jul 2022	Submitted	Original manuscript
22 Sep 2022	Reviewed	Reviewer Report
27 Sep 2022	Reviewed	Reviewer Report
16 Oct 2022	Author responded	Author comments - Andreas R. Gantenbein
Resubmission - Version 2
16 Oct 2022	Submitted	Manuscript version 2
Publishing
20 Oct 2022	Editorially accepted
18 Nov 2022	Article published	10.1186/s10194-022-01515-8

Back to article page